MEMANTINE TEVA

Main information

  • Trade name:
  • MEMANTINE TEVA Orodispersible tablet 20MG
  • Dosage:
  • 20MG
  • Pharmaceutical form:
  • Orodispersible tablet
  • Administration route:
  • Oral use
  • Units in package:
  • 120X1 Blister
  • Prescription type:
  • on prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • MEMANTINE TEVA Orodispersible tablet 20MG
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Memantine
  • Product summary:
  • POR TBL DIS 120X1X20MG

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • R - active MA/authorised medicinal product
  • Authorization number:
  • 06/ 271/13-C
  • Last update:
  • 24-11-2016

19-9-2018

Memantine Mylan (Mylan S.A.S.)

Memantine Mylan (Mylan S.A.S.)

Memantine Mylan (Active substance: Memantine) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)5972 of Wed, 19 Sep 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2660/T/12

Europe -DG Health and Food Safety

7-8-2018

Memantine Accord (Accord Healthcare Limited)

Memantine Accord (Accord Healthcare Limited)

Memantine Accord (Active substance: memantine) - Centralised - Renewal - Commission Decision (2018)5421 of Tue, 07 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2766/R/10

Europe -DG Health and Food Safety